A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts

A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts

عرض إصدارات أخرى (1)

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	van Leeuwen, N, Nijpels, G, Becker, M, Deshmukh, H, Zhou, K, Stricker, B, Uitterlinden, A, Hofman, A, van 't Riet, E, Palmer, C, Guigas, B, Slagboom, P, Durrington, P, Calle, R, Neil, A, Hitman, G, Livingstone, S, Colhoun, H, Holman, R, McCarthy, M, Dekker, J, 't Hart, L, Pearson, E
التنسيق:	Journal article
منشور في:	2012

مواد مشابهة

A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts.
حسب: van Leeuwen, N, وآخرون
منشور في: (2012)

A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of two Dutch and two UK cohorts
حسب: 't Hart, L, وآخرون
منشور في: (2011)

The role of ATM in response to metformin treatment and activation of AMPK.
حسب: Zhou, K, وآخرون
منشور في: (2012)

Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS).
حسب: Colhoun, H, وآخرون
منشور في: (2005)

Effect of atorvastatin on stroke in the collaborative atorvastatin diabetes study (CARDS): Factors predictive of the risk of stroke
حسب: Newman, C, وآخرون
منشور في: (2005)

Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes.
حسب: Thomason, M, وآخرون
منشور في: (2004)

Stroke prediction and stroke prevention with atorvastatin in the Collaborative Atorvastatin Diabetes Study (CARDS).
حسب: Hitman, G, وآخرون
منشور في: (2007)

Effect of atorvastatin in patients 65 years of age with type 2 diabetes: Subgroup analysis from the collaborative atorvastatin diabetes study (CARDS)
حسب: DeMicco, D, وآخرون
منشور في: (2005)

Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS).
حسب: Neil, H, وآخرون
منشور في: (2006)

Effect of atorvastatin on stroke in patients with type 2 diabetes: factors predicting the risk of stroke in the Collaborative Atorvastatin Diabetes Study (CARDS)
حسب: Hitman, G, وآخرون
منشور في: (2005)

Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).
حسب: Colhoun, H, وآخرون
منشور في: (2009)

Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial.
حسب: Colhoun, H, وآخرون
منشور في: (2011)

Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS).
حسب: Raikou, M, وآخرون
منشور في: (2007)

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
حسب: Colhoun, H, وآخرون
منشور في: (2004)

Change in Lp-PLA2 With Risk Change on Statin Therapy in the Collaborative Atorvastatin Diabetes Study (CARDS)
حسب: Betteridge, D, وآخرون
منشور في: (2009)

Role of Mitochondria in the Mechanism(s) of Action of Metformin
حسب: Guillaume Vial, وآخرون
منشور في: (2019-05-01)

Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis.
حسب: Zhou, K, وآخرون
منشور في: (2014)

Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes.
حسب: Zhou, K, وآخرون
منشور في: (2011)

Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
حسب: Zhou, K, وآخرون
منشور في: (2011)

Erratum: Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: The Collaborative Atorvastatin Diabetes Study (CARDS)
حسب: Charlton-Menys, V, وآخرون
منشور في: (2009)

Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetes.
حسب: Colhoun, H, وآخرون
منشور في: (2002)

Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS).
حسب: Charlton-Menys, V, وآخرون
منشور في: (2009)

Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS).
حسب: Charlton-Menys, V, وآخرون
منشور في: (2009)

Heritability of variation in glycaemic response to metformin: A genome-wide complex trait analysis
حسب: Zhou, K, وآخرون
منشور في: (2014)

Cost-effectiveness of atorvastatin (10mg) in patients with type 2 diabetes without coronary heart disease: CARDS trial analysis and extrapolation
حسب: Raikou, M, وآخرون
منشور في: (2005)

The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS).
حسب: Newman, C, وآخرون
منشور في: (2008)

Safety of atorvastatin in the collaborative AtoRvastatin diabetes study (CARDS)
حسب: Newman, C, وآخرون
منشور في: (2006)

C-reactive Protein and Amyloid A as Predictors of Cardiovascular Events in Type 2 Diabetes in CARDS
حسب: Charlton-Menys, V, وآخرون
منشور في: (2009)

Alterations in cellular energy metabolism associated with the antiproliferative effects of the ATM inhibitor KU-55933 and with metformin.
حسب: Mahvash Zakikhani, وآخرون
منشور في: (2012-01-01)

The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease.
حسب: Soedamah-Muthu, S, وآخرون
منشور في: (2003)

Metformin and mortality. Reply to Lund SS [letter]
حسب: Stevens, R, وآخرون
منشور في: (2013)

Metformin and mortality. Reply to Lund SS [letter].
حسب: Stevens, R, وآخرون
منشور في: (2013)

The effect of atorvastatin therapy on tumour necrosis factor-α and vascular adhesion molecules in patients with type 2 diabetes mellitus with no prior history of coronary heart disease
حسب: Soedamah-Muthu, S, وآخرون
منشور في: (2011)

Metformin and risk of cardiovascular disease.
حسب: Turner, R, وآخرون
منشور في: (1999)

Risk of anaemia with long-term metformin use in a community setting
حسب: Donnelly, L, وآخرون
منشور في: (2017)

The sustained influence of metformin therapy on circulating GLP-1 levels in individuals with and without type 2 diabetes
حسب: Preiss, D, وآخرون
منشور في: (2016)

ANALISIS TERHADAP PERLINDUNGAN HUKUM BAGI NASABAH PENGGUNA ATM (SKIMMING KARTU ATM PADA MESIN ATM BANK X)
حسب: , Ronald Arthur Saiya, وآخرون
منشور في: (2014)

Identifying the Latitude and Longitude of ATMs in ATM Networks
حسب: Niloofar Haghjoo, وآخرون
منشور في: (2024-06-01)

The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin
حسب: Elisabet Cuyàs, وآخرون
منشور في: (2019-03-01)

METFORMIN IN THE MANAGEMENT OF TYPE-2 DIABETES - REPLY
حسب: Holman, R, وآخرون
منشور في: (1989)